Dazheng Medical Reports 12.87% YoY Decline in H1 2020 Net Profit to RMB 11.71 Million Amid Reduced Product Sales

Source: Wabei.com

Wabei.com, August 24,GRED(430496) Recently released its 2020 semi-annual report. As of June 30, 2020, the company achieved an operating income of RMB 42,235,256.71 in the first half of 2020, a year-on-year decrease of 16.16%; the net profit attributable to shareholders of the listed company was RMB 11,706,413.89, a year-on-year decrease of 12.87%.

As of June 30, 2020, the Company’s total assets at the end of the reporting period amounted to RMB 173,095,109.33, representing a decrease of 4.09% compared to the end of the previous year; the net assets attributable to shareholders of the listed company amounted to RMB 165,403,852.13, representing an increase of 0.37% compared to the end of the previous year.

It is reported that during the reporting period, the company achieved an operating income of 42,235,256.71 yuan, a decrease of 16.16% compared to the same period last year; the net profit attributable to shareholders of the parent company was 11,706,413.89 yuan, a decrease of 12.87% compared to the same period last year. The main reason is that due to the impact of the COVID-19 pandemic, the company's sales and marketing activities were hindered to some extent, resulting in a reduction in product sales revenue.

According to data from Wabei.com, GRED is a high-tech enterprise specializing in medical devices, integrating research and development, production, sales, and services.